Investigation of key interactions between the second extracellular loop of the dopamine D2 receptor and several hydroxy-N-{[2-(4-phenylpiperazin-1-yl)ethyl]phenyl}nicotinamides by Šukalović, Vladimir et al.
  
J. Serb. Chem. Soc. 79 (12) 1461–1467 (2014) UDC 547.53.024+547.861.3+544.723.232+ 
JSCS–4679 539.196:547.233–304.2 
 Original scientific paper 
1461 
Investigation of key interactions between the second 
extracellular loop of the dopamine D2 receptor and several 
hydroxy-N-{[2-(4-phenylpiperazin-1-yl)ethyl]phenyl}- 
nicotinamides 
VLADIMIR ŠUKALOVIĆ1*, VUKIĆ ŠOŠKIĆ2, DJURDJICA IGNJATOVIĆ3, 
DEANA ANDRIĆ4, JELENA PENЈIŠEVIĆ1 and SLADJANA KOSTIĆ-RAJAČIĆ1 
1ICTM – Department of Chemistry, University of Belgrade, Njegoševa 12, 11000 Belgrade, 
Serbia, 2ORGENTEC Diagnostika GmbH, Carl-Zeiss-Str. 49, 55129 Mainz, Germany, 
3Institute for Biological Research “Siniša Stanković”, University of Belgrade, Bulevar 
despota Stefana 142, 11060 Belgrade, Serbia and 4Faculty of Chemistry, University of 
Belgrade, Studentski trg 12–16, 11000 Belgrade, Serbia 
(Received 23 April, revised 2 July, accepted 6 July 2014) 
Abstract: The dopaminergic receptor system has been the focus for the deve-
lopment of new pharmacotherapeutic agents targeting a number of central 
nervous system related disorders, such as drug addiction, schizophrenia, dep-
ression, and Parkinson’s disease, to name just a few. To date, the crystal struc-
ture for the human D2 receptor is not known, despite its vital function and 
importance as a therapeutic target. Herein, a recent advancement in the 
determination of key receptor–ligand interactions for the available arylpiper-
azine-like ligands, using a D2 receptor model based on the crystal structure of 
the D3 receptor is presented. To determine key interactions responsible for 
high dopaminergic activity, computer-docking analysis was used together with 
experimental data. A total of 4 dopaminergic ligands showing moderate to high 
affinity were tested and the obtained results rationalized using ligand structures 
docked into the proposed D2 receptor model. 
Keywords: arylpiperazine; G protein-coupled receptors; docking; molecular 
modeling. 
INTRODUCTION 
The second extracellular loop (ECL) of dopamine D2 (D2DA) receptors is a 
part of the ligand-binding site. The exact 3D structure of this receptor domain is 
so far unknown.1 The crystal structure for the ECL receptor area of G protein- 
-coupled receptors (GPCRs) is not available because of the high flexibility of that 
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receptor domain. Still ECLs plays a significant role in ligand–receptor inter-
actions and therefore it is important to learn more about the molecular processes 
involved in the ligand binding. A study of the structural and functional roles of 
extracellular loops may help in the understanding of certain aspects of ligand 
binding affinity that cannot be fully explained by interactions with the canonical 
binding site located in the transmembrane part of the receptor. 
Several attempts were made to establish key receptor–ligand interactions in 
the ECL area1,2 by using the methods of molecular modeling. In this paper, 
results are published that were obtained through an investigation of receptor– 
–ligand interactions in the ECL area of D2DAR, and a set of already available 
four hydroxy-N-{[2-(4-phenylpiperazin-1-yl)ethyl]phenyl]nicotinamides3 (Table 
I). For the sake of clarity, the ligand molecule was considered as a tail part (phe-
nylpiperazine), a linker part (meta- and para-amino-phenylethyl) and a head part 
(heteroaryl group). The tail part was kept constant, while the linker and head 
parts were varied as described below: 
– Ligand 1 is a long linear molecule able to protrude and to bind into the 
ECL receptor area. It contains polar groups in the head area to allow hydrogen 
TABLE I. Structures of the tested hydroxy-N-{[2-(4-phenylpiperazin-1-yl)ethyl]phenyl]nico-
tinamides, i.e., 6-hydroxy-N-{4-[2-(4-phenylpiperazin-1-yl)ethyl]phenyl}nicotinamide (1), 2-
-hydroxy-N-{4-[2-(4-phenylpiperazin-1-yl)ethyl]phenyl}nicotinamide (2), 6-hydroxy-N-{3-
-[2-(4-phenylpiperazin-1-yl)ethyl]phenyl}nicotinamide (3), 2-hydroxy-N-{3-[2-(4-phenylpi-
perazin-1-yl)ethyl]phenyl}nicotinamide (4), for binding to the D2DA receptors and the 
determined Ki values that are the mean of three independent experiments performed in tri-
plicate at 7 competing ligand concentrations 
No. R Ki / nM 
N N
R N
H
O
1 N
OH
19.5 
2 
N
OH 154.3 
3 N
OH
95.9 
4 
N
OH 120.1 
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bonding with D2DAR. 
– Ligand 2 is the same as ligand 1 but with an altered polar group arrange-
ment in the head part.  
– Ligand 3 is a meta-regioisomer of ligand 1, which makes it shorter and 
therefore suboptimal for binding into the ECL D2DAR area. 
– Ligand 4 is the same as ligand 3 but with an altered polar group arrange-
ment in the head part.  
In this way, it was assumed that only the hydrogen bond interaction between 
the ligand and receptor ECL area could be studied, while keeping all other inter-
actions constant. 
EXPERIMENTAL 
Biological assays 
Radioligand [3H]spiperone was purchased from Amersham Biosciences (Amersham, 
UK). CHO-hD2S cells stably expressing the native human D2DA receptor were obtained 
from Professor Phillip G. Strange (University of Reading, UK). The cell lines maintain the 
isolation of membranes with the D2DA receptor. Competition binding assays at the D2 DA 
receptor were performed using [3H]spiperone (0.4 nM) by the protocol provided in previous 
publications.4 Competition binding studies were performed with seven varied concentrations 
of the test compounds run in triplicate tubes, and isotherms from three assays were calculated 
by computerized nonlinear regression analysis to yield Ki values. 
Docking analysis 
A D2DR homology model, used in the docking analysis, was built using the crystal 
structure of D3DR as the template. The receptor binding site was defined to include all key 
amino acid residues, as described previously.2,5  
The 3D structures of the ligand were generated using the Discovery Studio program.6 
Assuming physiological conditions, the basic aliphatic nitrogen atom of piperazine was pro-
tonated. The geometry was optimized using the CHARMM force field applying the conjugate 
gradient method until the energy difference between successive cycles was below 0.0042 kJ 
mol-1.7  
Docking of the selected ligands as presented in Table 1 was realized by simulated 
annealing using the LIBDOCK module from Discovery Studio, employing the CHARMM 
force field. The initial position of the ligand in the binding site was arbitrary, while the pro-
tonated nitrogen on the ligand part was kept in close proximity to Asp 114 of the receptor. No 
further ligand constraints were applied. Up to 100 structures were produced in every run and 
each finally optimized in order to remove steric interaction with a gradient limit of 0.0042 kJ 
mol-1 or 4000 optimization steps. A structure was selected based on the following criteria: 
lowest total energy of the complex, shortest salt bridge formed between Asp 114 of the D2DR 
and protonated piperazine nitrogen, chair conformation of the arylpiperazine ring and the aryl 
part of the molecule positioned in the rear of the hydrophobic pocket of the receptor Phe 386, 
Trp 390 and Tyr 420.8 After these initial criteria were satisfied, a second step was performed 
to examine other interactions that could be formed between the receptor and ligand (hydrogen 
bonds, aromatic–aromatic interactions, etc.). In this way, the best possible docking structures 
were selected. The structures were visualized using DS Visualise, v. 2.5.16, and the obtained 
images were rendered using PovRay Raytracer, v. 3.6.9 
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Electronic surface potential (ESP) calculation 
The geometry of the ligands was further optimized in Gaussian 03W software10 using the 
DFT B3LYP method with a 6-31g* basis set. The geometry obtained in this way was used for 
calculation of the ESP. Only the head and linker part of the ligand were subjected to calcul-
ation, since the tail segment cannot influence the ESP distribution. The obtained results were 
visualized in gOpenMol.11 
RESULTS AND DISCUSSION 
The experimental results showed that all ligands bind to D2DR with mode-
rate to high affinity (Table I). The D2DAR receptor cavity is defined by two 
binding sites, i.e., the orthosteric binding site (OBS) located in the receptor inter-
ior and the second binding pocket (SBP).5 The OBS consists of the following 
amino acid residues: Asp 114, Ser 194, Ser 197, Ser 167, Trp 386, Phe 390 and 
Tyr 420. During ligand binding, the role of residue Asp 114 is to anchor via a salt 
bridge with the charged nitrogen atom. Residues Trp 386, Phe 390 and Tyr 420 
form a hydrophobic pocket inside the OBS. The hydrophobic tail segment of the 
ligand forms multiple edge-to-face (ETF) interactions with the pocket amino acid 
residues, resulting in correct orientation of the ligand inside the OBS. Ser 
194/197 and Ser 167 form additional hydrogen bonds that result in a high affinity 
complex.5,8 
The head segment of ligands 1–4 can interact with amino acid residues 
located in the SBP, including the ECL area (Ile 166, Leu 170, Leu 171, Ile 184, 
Phe 189, Val 190, His 397 and Ile 398). Amino acid residues Ile 166, Leu 170, 
Leu 171, Ile 184, Val 190 and Ile 398 can form hydrophobic interactions. Phe 
189 and His 397 are oriented in a way that allows edge-to-face interactions to 
occur. Ligand 1 can establish an additional hydrogen bond with Asn 186 (Fig. 1). 
 
Fig. 1. Docking results – 3D model of D2DR with the position of ligand 1 (black) inside the 
binding site. Only key amino acid residues are displayed for clarity. 
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The individual differences in the affinity of ligands could be explained by 
the obtained docking results.  
Ligand 1 was optimally positioned inside the binding site of the receptor, 
leading to a high affinity complex. Key interactions include a short salt bridge 
with Asp 114, the ligand tail part oriented between Trp 386, Phe 390 and Tyr 
420, forming several edge-to-face interaction, hydrogen bonds with Ser 194 and 
Ser 167, the ligand head part correctly oriented between Phe 189 and His 397, 
and a hydrogen bond between the ligand head part and Asn 186 (Fig. 2). 
 
Fig. 2. Schematic representation of the key interaction between D2DR and ligand 1 (top left), 
ligand 2 (top right), ligand 3 (bottom left) and ligand 4 (bottom right). The aromatic 
interactions are shown as solid lines, while hydrogen bonds and the salt bridge 
are denoted by dashed lines. 
Ligand 2 occupied the same space inside the D2DR but its head part could 
not form a hydrogen bond with Asn 186 due to the formation of an intramole-
cular hydrogen bond with the carbonyl oxygen. This led to reduced affinity for 
D2DR.  
Ligand 3, being shorter than ligand 1, could not benefit from the interaction 
with Asn 186, but retained some interactions in the ECL area. The docking 
results showed aromatic interactions with Phe 189 and His 397 but simultane-
ously, the positioning of the hydroxyl group of the head part of the ligand inside 
the mainly hydrophobic pocket diminished the formation of aromatic interaction 
with the surrounding hydrophobic groups. 
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Ligand 4, is a meta-isomer of ligand 2 and docks in a similar manner. Again 
the intramolecular hydrogen bond leads to a reduced number of interactions with 
D2DR, resulting in a receptor affinity in the same range as with ligand 2. 
The ligand affinity depended on the aromatic interactions within the OBS 
and SBP. These interactions were of the edge-to-face type and depended on the 
correct ESP distribution. The negative ESP in the aromatic part of the ligand tail 
segment, which forms the edge for ETF interactions with Trp 386 and Tyr 420 
(OBS), was preferred, which led to high ligand affinity.8 
The SBP amino acid residues Phe 189 and His 397 can establish ETF inter-
actions, contributing to ligand affinity. The ESP distribution in the head segment 
of the ligands 1–4 show that aromatic interactions with Phe 189 and His 397 
were possible via hydrogen atoms in the nicotinamide part of the molecule and 
the negative ESP on Phe 189 (the ligand is the edge and Phe 189 is face), and via 
the partially positively charged proton on His 397 and the negative ESP on the 
nicotinamide nitrogen in the ligand head part (Fig. 3). 
 
Fig. 3. ESP distribution in ligand 1 (top left), ligand 2 (top right), ligand 3 (bottom left) and 
ligand 4 (bottom right). Only the head and linker parts are shown for clarity. The negative 
ESP is shown in dark gray, while the positive ESP is shown in light gray. 
CONCLUSION 
In previous studies, a 3D model of D2DR was proposed; special focus was 
on molecular modeling of key receptor–ligand interactions in the ECL area.2,5 In 
this publication, the role of Phe 189, His 397 and Asn 186 in ligand binding was 
stressed. Phe 189 and His 397 provided aromatic type interactions while Asn 186, 
which is located in the middle of ECL2, provided hydrogen bonding interaction 
with 6-hydroxy-N-{4-[2-(4-phenylpiperazin-1-yl)ethyl]phenyl}nicotinamide. 
The obtained results showed that the ECL receptor area plays an important 
role in the binding of long linear-shaped ligands that cannot entirely fit into the 
canonical D2DR bind site. The ECL domain is a part of the receptor-binding site, 
and provides several key receptor–ligand interactions, leading to high affinity 
complexes.  
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И З В О Д  
ИСПИТИВАЊЕ КЉУЧНИХ ИНТЕРАКЦИЈА ИЗМЕЂУ ДРУГЕ ЕКСТРАЦЕЛУЛАРНЕ 
ПЕТЉЕ ДОПАМИНСКОГ D2 РЕЦЕПТОРА И РАЗЛИЧИТИХ ХИДРОКСИ-N-{[2-(4- 
-ФЕНИЛПИПЕРАЗИН-1-ИЛ)ЕТИЛ]ФЕНИЛ}-НИКОТИНАМИДА 
ВЛАДИМИР ШУКАЛОВИЋ1, ВУКИЋ ШОШКИЋ2, ЂУРЂИЦА ИГЊАТОВИЋ3, ДЕАНА АНДРИЋ4, 
ЈЕЛЕНА ПЕЊИШЕВИЋ1 и СЛАЂАНА КОСТИЋ-РАЈАЧИЋ1 
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Diagnostika GmbH, Carl-Zeiss-Str. 49, 55129 Mainz, Germany, 3Институт за биолошка истраживања 
„Синиша Станковић“, Универзитет у Београду, Булевар деспота Стефана 142, 11060 Београд и 
4Хемијски факултет, Универзитет у Београду, Студентски трг 12–16, 11000 Београд 
Допаминергички систем се већ дуже време налази у фокусу истраживања усмере-
них ка развоју нових фармакотерапијских супстанци, намењених лечењу обољења цен-
тралног нервног система (ЦНС), као што су: наркоманија, шизофренија, депресија и 
Паркинсонова болест. До данас, кристална стуктура допаминског D2 рецептора није 
позната, упркос његовој битној функцији и важности у циљаној терапији обољења ЦНС. 
У овом раду, представљамо напредак у одређивању кључних рецептор–лиганд интерак-
ција, између арилпиперазину сличних лиганaда и модела D2 рецептора добијеног на 
основу кристалне струкуре D3 рецептора. Употребом докинг анализе, упоредо са експе-
рименталним резултатима, одређене су кључне интеракције које доприносе високој доп-
аминергичкој активности. Укупно 4 лиганда арилпиперазинске структуре су тестирана, 
показала су умерени до високи афинитет везивања, а добијени резултати су објашњени 
путем доковања лиганада у предложени модел D2 рецептора. 
(Примљено 23. априла, ревидирано 2. јула, прихваћено 6. јула 2014) 
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